Long-Term Low-Dose Pyrimethamine Use for the Prevention of Ocular Toxoplasmosis Recurrences: A Cohort Study.

Yuslay Fernández ZamoraPaula M MarinhoJoão Rafael Oliveira DiasThiago CabralJulio CasoyCristina MuccioliHeloísa Moraes Do NascimentoRubens Belfort

Published in: Ocular immunology and inflammation (2024)

Long-term, low-dose pyrimethamine can be considered as a treatment option for the prevention of ocular toxoplasmosis recurrence in selected patients, with only a few, mild and reversible systemic adverse events.

Keyphrases

low dose
high dose
toxoplasma gondii
plasmodium falciparum